Literature DB >> 17110152

Pharmacovigilance for evaluating adverse drug reactions: value, organization, and methods.

Jean-Louis Montastruc1, Agnès Sommet, Isabelle Lacroix, Pascale Olivier, Geneviève Durrieu, Christine Damase-Michel, Maryse Lapeyre-Mestre, Haleh Bagheri.   

Abstract

Mesh:

Year:  2006        PMID: 17110152     DOI: 10.1016/j.jbspin.2006.09.002

Source DB:  PubMed          Journal:  Joint Bone Spine        ISSN: 1297-319X            Impact factor:   4.929


× No keyword cloud information.
  26 in total

1.  Trends of reporting of 'serious'vs. 'non-serious' adverse drug reactions over time: a study in the French PharmacoVigilance Database.

Authors:  Guillaume Moulis; Agnès Sommet; Geneviève Durrieu; Haleh Bagheri; Maryse Lapeyre-Mestre; Jean-Louis Montastruc
Journal:  Br J Clin Pharmacol       Date:  2012-07       Impact factor: 4.335

2.  Psychiatric adverse drug reactions to glucocorticoids in children and adolescents: a much higher risk with elevated doses.

Authors:  Neda Tavassoli; Julie Montastruc-Fournier; Jean Louis Montastruc
Journal:  Br J Clin Pharmacol       Date:  2008-05-15       Impact factor: 4.335

3.  Detecting a potential safety signal of antidepressants and type 2 diabetes: a pharmacovigilance-pharmacodynamic study.

Authors:  Spyridon Siafis; Georgios Papazisis
Journal:  Br J Clin Pharmacol       Date:  2018-07-28       Impact factor: 4.335

4.  Atropinic burden of prescriptions forms in patients with Alzheimer disease: a cross-sectional study in a French PharmacoVigilance Database.

Authors:  François Montastruc; Sarah Rouanet; Virginie Gardette; Vanessa Rousseau; Haleh Bagheri; Jean-Louis Montastruc
Journal:  Eur J Clin Pharmacol       Date:  2015-05-21       Impact factor: 2.953

5.  Preventable and potentially preventable serious adverse reactions induced by oral protein kinase inhibitors through a database of adverse drug reaction reports.

Authors:  Adeline Egron; Pascale Olivier-Abbal; Aurore Gouraud; Samy Babai; Sandrine Combret; Jean-Louis Montastruc; Emmanuelle Bondon-Guitton
Journal:  Target Oncol       Date:  2014-07-25       Impact factor: 4.493

6.  Potentially inappropriate medications and adverse drug reactions in the elderly: a study in a PharmacoVigilance database.

Authors:  François Montastruc; Cannelle Duguet; Vanessa Rousseau; Haleh Bagheri; Jean-Louis Montastruc
Journal:  Eur J Clin Pharmacol       Date:  2014-06-14       Impact factor: 2.953

7.  Do Parkinson's disease patients disclose their adverse events spontaneously?

Authors:  Santiago Perez-Lloret; María Verónica Rey; Nelly Fabre; Fabienne Ory; Umberto Spampinato; Jean-Louis Montastruc; Olivier Rascol
Journal:  Eur J Clin Pharmacol       Date:  2011-12-29       Impact factor: 2.953

8.  Comparison of serious adverse reactions between thalidomide and lenalidomide: analysis in the French Pharmacovigilance database.

Authors:  Pascale Olivier-Abbal; Anne-Charlotte Teisseyre; Jean-Louis Montastruc
Journal:  Med Oncol       Date:  2013-09-28       Impact factor: 3.064

9.  Adverse drug reactions to gabapentin and pregabalin: a review of the French pharmacovigilance database.

Authors:  Régis Fuzier; Isabelle Serres; Emmanuelle Guitton; Maryse Lapeyre-Mestre; Jean-Louis Montastruc
Journal:  Drug Saf       Date:  2013-01       Impact factor: 5.606

10.  Adverse drug reactions in hospitalized pediatric patients of Saudi Arabian University Hospital and impact of pharmacovigilance in reporting ADR.

Authors:  Lateef M Khan; Sameer E Al-Harthi; Omar I Saadah
Journal:  Saudi Pharm J       Date:  2012-10-06       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.